Zapping cancer spots: new hope for kidney patients on immunotherapy?
NCT ID NCT04974671
First seen Jan 03, 2026 · Last updated Apr 30, 2026 · Updated 23 times
Summary
This study tests whether precisely targeted radiation (SBRT) can stop or slow the growth of a few new cancer spots in patients with metastatic kidney cancer who are already on immunotherapy. About 30 adults will receive radiation to up to 5 progressing tumors while continuing their current medication. The goal is to see if this approach extends the time before the cancer worsens.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for RENAL CELL CARCINOMA are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Yale University
RECRUITINGNew Haven, Connecticut, 06520, United States
Conditions
Explore the condition pages connected to this study.